These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30691415)

  • 1. Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.
    McLaughlin PJ; Sassani JW; Titunick MB; Zagon IS
    BMC Ophthalmol; 2019 Jan; 19(1):35. PubMed ID: 30691415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
    Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ
    Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.
    Zagon IS; Klocek MS; Sassani JW; McLaughlin PJ
    Arch Ophthalmol; 2009 Nov; 127(11):1468-73. PubMed ID: 19901212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
    Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
    Exp Eye Res; 2009 Nov; 89(5):686-92. PubMed ID: 19576213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
    McLaughlin PJ; Pothering CA; Immonen JA; Zagon IS
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1122-32. PubMed ID: 21917593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats.
    Immonen JA; Zagon IS; Lewis GS; McLaughlin PJ
    Exp Biol Med (Maywood); 2013 Oct; 238(10):1127-35. PubMed ID: 23986225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
    Zagon IS; Sassani JW; Carroll MA; McLaughlin PJ
    Brain Res Bull; 2010 Feb; 81(2-3):248-55. PubMed ID: 19853024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways.
    Zagon IS; Campbell AM; Sassani JW; McLaughlin PJ
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):3234-40. PubMed ID: 22511629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
    Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):89-102. PubMed ID: 17444796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium.
    Zagon IS; Sassani JW; Myers RL; McLaughlin PJ
    Brain Res Bull; 2007 Apr; 72(1):18-24. PubMed ID: 17303503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal safety of topically applied naltrexone.
    Zagon IS; Klocek MS; Sassani JW; Mauger DT; McLaughlin PJ
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):377-87. PubMed ID: 17076633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats.
    Purushothaman I; Zagon IS; Sassani JW; Mclaughlin PJ
    Exp Ther Med; 2021 Jul; 22(1):687. PubMed ID: 33986852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.
    Zagon IS; Sassani JW; McLaughlin PJ
    Cornea; 2006 Aug; 25(7):821-9. PubMed ID: 17068460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications.
    Zagon IS; Sassani JW; Purushothaman I; McLaughlin PJ
    Exp Biol Med (Maywood); 2021 Mar; 246(5):629-636. PubMed ID: 33203224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease.
    Schmidl D; Szalai L; Kiss OG; Schmetterer L; Garhöfer G
    Adv Ther; 2021 Apr; 38(4):1975-1986. PubMed ID: 33710587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
    McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS
    Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
    Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
    Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
    Chen T; Powell CC
    Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
    Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
    Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.